A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer
OPEN TO ACCRUAL
I/II
NCT06996782
hina.khan@BrownHealth.org